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Objective: To assess the outcome of cardiac catheterization or percutaneous coronary intervention (PCI) in patients with end stage liver disease 
(ESLD) awaiting orthotopic liver transplant (OLT).
Background: There is little data about adverse events and bleeding complications during cardiac catheterization in ESLD patients who have an 
increased risk with arterial punctures. In addition, it is unclear if PCI impacts the survival rate in ESLD patients with coronary artery disease (CAD).
Methods: The records of patients with ESLD awaiting OLT who underwent cardiac catheterization from January 2006 to June 2011 were 
reviewed. The severity of CAD and the outcome of PCI were evaluated. The pre-operative non-invasive stress tests were compared with the coronary 
angiographic findings. Death rates were compared in patients segregated by presence of CAD, OLT, or PCI.
Results: Of the 301 records reviewed, 47 patients (15.5%) were diagnosed with CAD on angiography and 33 (70%) of them had PCI. 106 patients 
(35%) received an OLT. Of 94 (31%) deaths, the majority (82/94) were from liver disease. Peri-catheterization bleeding episodes occurred in only 4 
patients (1%); classified as TIMI Minor (1) and TIMI Minimal (3). The sensitivity and specificity of Lexiscan Myoview Stress Test were 50% and 91%, 
and for Adenosine Stress Test: 61.5% and 93.5%. The prevalence of patients on dialysis-pre-catheterization was significantly higher in those with CAD 
compared to those ESLD patients without CAD (p=0.04). The death rate in all patient groups was similar; the mean age at the time of death was the 
highest in patients who underwent PCI prior to OLT.
Conclusions: The incidence of bleeding events after cardiac catheterization using the femoral artery in ESLD patients is low. Both Lexiscan and 
Adenosine Stress Tests have low sensitivity for diagnosing CAD in this patient population. Aggressive diagnosis and management in patients with CAD 
demonstrates a post-OLT survival rate similar to ESLD patients without CAD.
